Literature DB >> 8071690

The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease.

D O'Mahony1, J Coffey, J Murphy, N O'Hare, D Hamilton, P Freyne, J B Walsh, D Coakley.   

Abstract

UNLABELLED: In most semiquantitative SPECT studies, overlap between groups of patients with Alzheimer's disease (AD) and age-matched elderly controls is such that single posterior cortical perfusion measurements lack sensitivity. In the present study, the value of a combination of semiquantitative temporoparietal SPECT parameters was examined.
METHODS: Supratentorial transaxial perfusion measurements were obtained in frontal, anterior temporal, posterior temporoparietal and occipital cortical areas in both hemispheres, in a baseline population of 10 healthy elderly controls and 30 mild to moderately impaired AD patients, as well as in a prospective group of 15 patients with mild cognitive impairment, 12 patients with a diagnosis of probable AD and individual cases of multi-infarct dementia, dementia-frontal type and paranoid psychosis. A linear discriminant function (LDF) was calculated from the baseline subjects' data to classify control and AD subjects individually.
RESULTS: Highly significant hypoperfusion was noted in both the anterior temporal and posterior temporoparietal regions of interest in the AD group compared with controls, but with significant overlap. Using an LDF incorporating these perfusion measurements in both hemispheres, 10/10 (100%) controls and 26/30 (87%) AD baseline subjects were correctly classified. Using the baseline LDF in the prospective 15 mildly impaired cases, 11/12 new mild AD cases and none of the 3 non-AD cases were classified in the AD group.
CONCLUSION: These results support the use of a combination of semiquantitative SPECT perfusion estimates from cortical areas with predictable pathological involvement in AD in a linear discriminant format in the clinical assessment of patients with suspected AD.

Entities:  

Mesh:

Year:  1994        PMID: 8071690

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

Review 1.  A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile.

Authors:  Konstantine K Zakzanis; Simon J Graham; Zachariah Campbell
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

2.  Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load.

Authors:  A Bozzao; R Floris; M E Baviera; A Apruzzese; G Simonetti
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

3.  Changes in local cerebral blood flow by neuroactivation and vasoactivation in patients with impaired cognitive function.

Authors:  W H Knapp; C Dannenberg; B Marschall; D Zedlick; K Löschmann; S Bettin; H Barthel; A Seese
Journal:  Eur J Nucl Med       Date:  1996-08

4.  A new approach for improving diagnostic accuracy in Alzheimer's disease and frontal lobe dementia utilising the intrinsic properties of the SPET dataset.

Authors:  Marco Pagani; Vassili A Kovalev; Roger Lundqvist; Hans Jacobsson; Stig A Larsson; Lennart Thurfjell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-29       Impact factor: 9.236

Review 5.  Systematic review of the diagnostic utility of SPECT imaging in dementia.

Authors:  Jing Ming Yeo; Xuxin Lim; Zubair Khan; Suvankar Pal
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-08-06       Impact factor: 5.270

Review 6.  The Legacy of the TTASAAN Report-Premature Conclusions and Forgotten Promises: A Review of Policy and Practice Part I.

Authors:  Dan G Pavel; Theodore A Henderson; Simon DeBruin
Journal:  Front Neurol       Date:  2022-03-28       Impact factor: 4.086

7.  Prediction of outcomes in MCI with (123)I-IMP-CBF SPECT: a multicenter prospective cohort study.

Authors:  Kengo Ito; Etsuro Mori; Hidenao Fukuyama; Kazunari Ishii; Yukihiko Washimi; Takashi Asada; Satoru Mori; Kenichi Meguro; Shin Kitamura; Haruo Hanyu; Seigo Nakano; Hiroshi Matsuda; Yasuo Kuwabara; Kazuo Hashikawa; Toshimitsu Momose; Yoshitaka Uchida; Jun Hatazawa; Satoshi Minoshima; Kenji Kosaka; Tatsuo Yamada; Yoshiharu Yonekura
Journal:  Ann Nucl Med       Date:  2013-09-06       Impact factor: 2.668

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.